Routine albumin surveillance may help identify high-risk patients and prompt targeted interventions - nutritional optimization, infection/inflammation management, and dialysis adequacy checks - to reduce healthcare utilization and improve clinical outcomes. This evidence concerns the gene ALB and infection.